Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Withus Pharmaceutical Co Ltd banner
W

Withus Pharmaceutical Co Ltd
KOSDAQ:330350

Watchlist Manager
Withus Pharmaceutical Co Ltd
KOSDAQ:330350
Watchlist
Price: 9 190 KRW -1.61%
Market Cap: ₩121.3B
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

Operating Cash Flow
+
3Y
-16%
5Y
+155%
10Y
-
Investing Cash Flow
+
3Y
+95%
5Y
+87%
10Y
-
Financing Cash Flow
+
3Y
-72%
5Y
-88%
10Y
-

Cash Flow Statement
Withus Pharmaceutical Co Ltd

Rotate your device to view
Cash Flow Statement
Currency: KRW
Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Operating Cash Flow
Net Income
3 549
1 867
6 006
3 777
4 055
4 264
5 089
5 282
5 424
2 479
1 057
1 606
3 264
7 959
9 194
7 652
6 725
4 785
4 412
5 980
6 262
Depreciation & Amortization
1 082
988
1 698
1 680
1 583
1 501
1 628
1 755
1 865
1 948
2 026
2 188
2 483
2 844
3 212
3 480
3 650
3 778
3 876
3 953
4 023
Stock-Based Compensation
0
179
267
357
442
320
0
0
0
179
0
0
0
0
0
0
0
0
0
0
0
Other Non-Cash Items
608
12
1 035
1 059
2 084
1 645
2 019
2 098
2 463
3 010
2 509
2 588
560
413
1 395
1 053
1 822
1 722
1 602
1 068
1 415
Cash Taxes Paid
786
996
1 629
1 169
1 178
242
568
954
1 862
2 029
1 986
1 870
1 064
1 021
699
575
489
407
502
460
459
Cash Interest Paid
154
165
320
315
304
327
349
432
537
632
695
718
694
727
769
813
857
786
883
855
818
Change in Working Capital
(2 218)
(2 463)
(5 214)
(3 416)
(3 272)
612
535
1 003
(606)
(2 057)
(2 531)
(5 014)
(5 767)
(12 453)
(12 548)
(14 165)
(8 395)
(655)
599
2 975
(4 000)
Cash from Operating Activities
3 021
N/A
405
-87%
3 524
+771%
3 100
-12%
4 451
+44%
8 021
+80%
9 271
+16%
10 139
+9%
9 146
-10%
5 380
-41%
3 061
-43%
1 369
-55%
540
-61%
(1 237)
N/A
1 252
N/A
(1 980)
N/A
3 803
N/A
9 630
+153%
10 490
+9%
13 976
+33%
7 700
-45%
Investing Cash Flow
Capital Expenditures
(4 797)
(3 612)
(6 549)
(5 510)
(9 745)
(10 294)
(12 163)
(14 525)
(16 369)
(17 824)
(18 681)
(19 253)
(12 990)
(12 002)
(11 824)
(8 519)
(8 629)
(6 562)
(4 356)
(3 922)
(2 825)
Other Items
(4 091)
(6 050)
(6 184)
(6 322)
(2 896)
(4 641)
(3 484)
(7 608)
(7 315)
9 932
20 696
29 312
29 679
15 225
4 046
1 409
1 110
2 932
2 692
2 016
1 660
Cash from Investing Activities
(8 887)
N/A
(9 662)
-9%
(12 733)
-32%
(11 832)
+7%
(12 642)
-7%
(14 935)
-18%
(15 647)
-5%
(22 133)
-41%
(23 684)
-7%
(7 892)
+67%
2 015
N/A
10 060
+399%
16 689
+66%
3 223
-81%
(7 779)
N/A
(7 109)
+9%
(7 519)
-6%
(3 630)
+52%
(1 664)
+54%
(1 906)
-15%
(1 166)
+39%
Financing Cash Flow
Net Issuance of Common Stock
0
0
0
(18)
(36)
(54)
1
19
37
37
0
0
0
85
84
0
0
(1)
(1)
0
0
Net Issuance of Debt
740
1 441
1 241
3 804
6 136
5 730
4 611
8 873
7 518
(1 710)
(2 234)
(10 392)
(8 821)
(1 909)
(1 479)
2 755
938
4 041
(669)
1 291
1 957
Cash Paid for Dividends
0
(1 802)
0
(2 224)
(2 224)
(422)
0
(633)
(633)
(633)
0
0
0
0
0
(1 319)
(1 319)
(1 319)
0
0
0
Other
0
(33)
0
0
(51)
(18)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
16 779
N/A
(395)
N/A
15 450
N/A
1 528
-90%
3 825
+150%
5 254
+37%
4 172
-21%
8 241
+98%
6 922
-16%
(2 307)
N/A
(2 867)
-24%
(10 392)
-262%
(8 821)
+15%
(1 825)
+79%
(1 396)
+24%
1 521
N/A
(296)
N/A
2 721
N/A
(1 988)
N/A
1 290
N/A
1 956
+52%
Change in Cash
Effect of Foreign Exchange Rates
(1)
(4)
(3)
(4)
(2)
(0)
(1)
2
6
0
0
0
0
0
0
0
0
0
0
(0)
0
Net Change in Cash
10 913
N/A
(9 656)
N/A
6 239
N/A
(7 207)
N/A
(4 367)
+39%
(1 660)
+62%
(2 205)
-33%
(3 751)
-70%
(7 610)
-103%
(4 819)
+37%
2 209
N/A
1 036
-53%
8 409
+711%
162
-98%
(7 922)
N/A
(7 568)
+4%
(4 013)
+47%
8 720
N/A
6 838
-22%
13 360
+95%
8 491
-36%
Free Cash Flow
Free Cash Flow
(1 775)
N/A
(3 207)
-81%
(3 025)
+6%
(2 410)
+20%
(5 294)
-120%
(2 273)
+57%
(2 892)
-27%
(4 386)
-52%
(7 223)
-65%
(12 445)
-72%
(15 620)
-26%
(17 884)
-14%
(12 450)
+30%
(13 239)
-6%
(10 572)
+20%
(10 498)
+1%
(4 827)
+54%
3 067
N/A
6 134
+100%
10 054
+64%
4 875
-52%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 320,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.